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Abstract
Background: Endophthalmitis caused by non-tuberculous mycobacteria (NTM) is a rare condition seen after
surgery and trauma. This study reports a retrospective, consecutive, non-comparative case series of 5 patients
referred to L. V. Prasad Eye Institute, Hyderabad, and diagnosed with culture-proven NTM endophthalmitis between
January 2004 and April 2015. Data collected included demographic information, presenting features, microbiology
investigation, treatment course, and final visual outcome.
Results: Of 5555 clinically diagnosed infective endophthalmitis patients, vitreous samples were culture positive
for bacteria in 1541 (27.7 %). The isolates from five (0.32 %) patients were identified as NTM. The clinical
settings included post-cataract surgery (n = 3), post-vitrectomy (n = 1), and Descemet’s stripping endothelial
keratoplasty (n = 1). The species of NTM identified were Mycobacterium chelonae (n = 3), Mycobacterium
manitobense (n = 1), and Mycobacterium fortuitum (n = 1). All isolates were sensitive to amikacin while three
of the five isolates were sensitive to vancomycin. Initial treatment strategies included pars plana vitrectomy
with intravitreal antibiotic (vancomycin and amikacin) injection (n = 3), additional intraocular lens explant (n =
1), and silicone oil removal in the patient with post-vitreo-retinal surgery. Intravitreal steroid along with
antibiotics were given in three patients. Final outcome was favourable (20/200) in one patient, two eyes had
unfavourable outcome with multiple recurrences, one was advised evisceration, and one resulted in phthisis
bulbi.
Conclusions: This communication reports a series of five cases of NTM endophthalmitis. Poor outcome
despite cultureguided therapy suggests virulent nature of the organisms and the need for better treatment
strategies.
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Background
Mycobacteria other than Mycobacterium tuberculosis are
termed as atypical mycobacteria or non-tuberculous
mycobacteria (NTM). The first reported ocular infection
by NTM was a case of chronic keratitis caused by
Mycobacterium fortuitum, following the removal of a
corneal foreign body in 1965 [1]. Since then, these
micro-organisms have been implicated in the aetiology
of a variety of ocular infections. NTM are found ubiqui-
tously in the environment in soil, dust, and water [1, 2].
These atypical mycobacteria can be acquired from the
natural environment and nosocomially. Infections
caused by NTM range from external adnexal infections
[3] to keratitis [4–6], scleritis [7], uveitis [8], endophthal-
mitis [9–11], and panophthalmitis [1]. Risk factors for
ocular NTM infections include trauma, previous cor-
neal infection or surgery, corticosteroid use, and systemic
immunosuppression [11]. Although NTM are found to be
sensitive to the commonly used antibiotics including
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quinolones and aminoglycosides, their susceptibility may
vary [12].
The cases of NTM endophthalmitis reported in the
literature [9, 10, 13, 14] have been mostly preceded by
an intervention (28/37 eyes, 75.7 %), mainly cataract
surgery with intraocular lens (IOL) insertion (18/37 eyes,
48.6 %) [14]. Other predisposing procedures included
penetrating keratoplasty, intravitreal injection, scleral
buckling, filtering surgery, and Descemet’s stripping
automated endothelial keratoplasty or DSAEK (1 eye,
2.7 %) [14, 15]. Herein, we report five cases of culture-
proven NTM endophthalmitis. The purpose of this
study is to report our experience with the risk factors,
microbiological results, clinical findings, response to
therapy, and the clinical outcome in patients with this
rare disease.
Methods
This study is a retrospective, consecutive, non-comparative
review of medical and microbiology records of all patients
diagnosed and treated for NTM endophthalmitis. The pa-
tients reported at L. V. Prasad Eye Institute, Hyderabad,
India, between January 2004 and April 2015 with postoper-
ative endophthalmitis after having undergone certain ocu-
lar surgical procedures elsewhere. The study was approved
by institutional review board (LEC-06-15-070) and has
been performed in accordance with the ethical standards
as laid down in the 1964 Declaration of Helsinki. Data
collected included demographic details, cause and duration
of symptoms, presenting and final visual acuity, surgical
interventions, and microbiology data. All patients had
undergone complete eye examination including slit lamp
biomicroscopy and indirect ophthalmoscopy. Ultrasound B
scan was done in all eyes where the fundus view was hazy.
Vitrectomy was done in all cases, and at the time of vitrec-
tomy, all eyes received intravitreal antimicrobial injection
with or without corticosteroid. The individual treating
physicians made treatment and management decisions.
Additional intravitreal injections were given whenever
indicated. Vitreous sample was sent immediately to the
microbiology laboratory. Explanted IOL and anterior cham-
ber exudate was also sent for culture, wherever indicated.
The smears for microscopy were made from undiluted
vitreous/aqueous samples and stained with calcofluor
white, Gram, and Giemsa stains. The samples were also
inoculated directly onto two 5 % sheep blood agar and
one each of 5 % sheep blood chocolate agar, Sabouraud
dextrose agar, potato dextrose agar, thioglycollate broth,
and brain-heart infusion broth. All media were incubated
at 37 °C except the Sabouraud dextrose agar and the
potato dextrose agar, which were incubated at 25–27 °C
for a period of 7 days. Chocolate agar was incubated in
the presence of 5 % CO2, and blood agar for anaerobic
culture was incubated in anaerobic pouch (Himedia,
Mumbai). All other media were incubated aerobically.
A culture was considered positive when there was
growth of the same organism on two or more media,
and/or confluent growth at the site of inoculation on
one solid medium, and/or growth in one medium
with consistent microscopy findings. Only unequivocal
or significant culture results were considered for in-
clusion in the study. In case of positive cultures, the
bacteria were further processed for identification and
antibiotic susceptibility testing. All isolates were iden-
tified by conventional biochemical tests. Identification
of one isolate was confirmed by polymerase chain re-
action (PCR)-based 16S ribosomal DNA (rDNA) se-
quencing [16]. In most cases, treatment was started
based on smear report. If response to medication was
inadequate, the treatment was modified according to
the culture and antibiotic susceptibility report from
the laboratory.
Results
Of 5555 clinically diagnosed infective endophthalmitis
patients investigated during the study period, vitreous
samples were culture positive for bacteria in 1541
(27.7 %). In five patients (0.32 %), the isolates were iden-
tified as NTM. The demographics and clinical setting
for each case is summarized in Table 1.
There were three females (60 %) and two males (40 %)
in the study group, and the age range was from 32 to
69 years with a mean of 49.4 ± 17.34 years. The time
interval between the onset of infection and the initial
presentation ranged from 13 to 300 days (mean 95.4 ±
17.34 days). Clinical settings included post-cataract
surgery in three patients (uncomplicated phacoemulsifi-
cation in one and manual small incision cataract surgery
in the other and the third one after extracapsular cata-
ract extraction), vitreo-retinal surgery in one patient for
rhegmatogenous retinal detachment, and Descemet’s
stripping endothelial keratoplasty (DSEK) for pseudo-
phakic bullous keratopathy in one. Initial ultrasound B
scans showed low reflective membranous echoes in vit-
reous with attached retina in all patients with increased
choroidal thickness (mean, 1.62 mm).
The major symptoms at presentation were pain, red-
ness, watering, and defective vision. Visual acuity at
presentation ranged from light perception in three pa-
tients (60 %), counting fingers at 1 m in one (20 %), and
counting fingers at 3 m in another (20 %). While the
view of the fundus was hazy in patient no. 2, the infec-
tion was seen to evolve rapidly and was characterized by
a marked anterior chamber reaction, hypopyon, and a
severe vitreous humour inflammatory reaction in others.
None of these patients had corneal involvement. Four
out of five (80 %) patients underwent pars plana vitrec-
tomy with intravitreal antibiotics (vancomycin 1 mg/
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0.1 ml and amikacin 0.4 mg/0.1 ml or ceftazidime).
While one (20 %) patient had intravitreal dexamethasone
along with the antibiotic initially, two other patients
were given intravitreal dexamethasone during their
secondary intervention. Based on clinical suspicion of
fungal involvement, two patients were given intravitreal
amphotericin B (5 μg/0.1 ml) and one had intravitreal
voriconozole. All patients were also started on topical
ciprofloxacin, atropine, and prednisolone acetate eye
drops. None of the patients were clinically immunocom-
promised. Additional treatments were tailored according
to the response of the eye, and the recurrences were
treated appropriately with appropriate antibiotics guided
by the sensitivity report.
Patient no. 3 developed scleral abscesses at the area of
the sclerotomies after initial vitreo-retinal procedure
(Fig. 1). On final follow-up, she had no light perception
with neovascular glaucoma and retinal detachment and
was advised evisceration. Of the five patients, only one
had a favourable visual outcome (patient no. 1) with late
onset endophthalmitis. This patient had presented with
visual acuity of counting fingers at 3 m which improved
to a final visual acuity of 20/200. Patient no. 2 had phthi-
sis bulbi at the final follow-up, and the other two were
quiet after multiple low-grade recurrences, and the final
visual acuity was unfavourable in all these cases.
The microbiology findings of the clinical samples are
summarized in Table 2. Direct microscopy of smears from
vitreous samples was positive in two out of five samples.
Based on observation of partially stained beaded bacilli
seen in Gram stain, the presence of Mycobacterium spe-
cies was suspected. The smears showed acid fast slender
beaded bacilli when restained with Ziehl-Neelsen (ZN)
stain (Fig. 2a). In all cases, within 3 days, there was growth
of confluent, dry, white colonies on both blood agar
(Fig. 2b) and chocolate agar, as well as turbid growth in
brain-heart infusion broth in four cases and thioglycollate
broth in three cases. Conventional biochemical tests iden-
tified three isolates as Mycobacterium chelonae and one
isolate was Mycobacterium fortuitum. The fifth isolate was
identified to be Mycobacterium manitobense using DNA
sequencing. All isolates were sensitive to amikacin, but
three isolates were resistant to vancomycin. Four isolates
were resistant to ciprofloxacin, and one was resistant to
Fig. 1 Non-tuberculous mycobacteria endophthalmitis after cataract surgery (patient no. 3). a Clinical photograph showing conjunctival congestion,
corneal edema, and hypopyon in the anterior chamber. b Multiple scleral abscesses at the sites of previous sclerotomy and dark brown exudates in
the anterior chamber
Table 1 Clinical profile of five patients with non-tuberculous mycobacterial endophthalmitis












1 32 F ECCE+
PCIOL
300 AC reaction, endoexudates,
vitritis grade 2
CF3M PPV + IOAB
(V + C)
NIL Favourable – 20/200
2 32 M BB+ PPV+
EL+SOI
13 AC reaction, endoexudates,
vitritis grade 4
PL+ SOR + IOAB
(V + C + amp B)
V + C Unfavourabe Phthisis PL-
3 69 F PHACO +
IOL
90 Hypopyon, pas, exudative
membrane on IOL, vitritis
grade 4
PL+ PPV + IOAB
(V + amp B)
V + A +
Dx
Unfavourable Evisceration PL-
4 50 M SICS+
PCIOL
29 Hypopyon, vitritis grade 3 CF 1m PPV + VIT BX +
IOAB (V + Vo)





5 64 F DSEK 45 PAS+, AC reaction, vitritis 3+ PL+ PPV + IOL Explant
+ IOAB (V + Dx)
V + Dx Unfavourable Recurrent vitritis,
optic atrophy
PL+
M male; F female; HM hand movements; LP light, perception; SICS small incision cataract surgery; ECCE extra capsular cataract extraction; PCIOL posterior chamber
intraocular lens; PPV pars plana vitrectomy; SOI silicone oil injection; SOR silicone oil removal; DSEK Descemet’s stripping endothelial keratoplasty; IOAB intraocular
antibiotics; V vancomycin; C ceftazidime; A amikacin; amp B amphotericin B; Dx dexamethasone; BCVA best-corrected visual acuity; CF counting fingers; PL+ accurate
projection of light; PR+ accurate projection of rays
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ofloxacin. M. manitobense, however, was sensitive to all
antibiotics tested.
Discussion
This study demonstrates that NTM endophthalmitis are
rare nosocomial infection that can pose both diagnostic
and therapeutic challenges. All patients had postoperative
endophthalmitis following different types of surgery. None
of them were related to trauma. In a recent study of 19
study patients with NTM endophthalmitis, the clinical
setting also included post-cataract surgery, post-glaucoma
implant, post-intravitreal injection, endogenous endoph-
thalmitis, post-pars plana vitrectomy, and post-scleral
buckle exposure [15]. Eyes with implants are reported to
Table 2 Microbiology profile of five patients with non-tuberculous mycobacterial endophthalmitis showing type of species and their
antibiotic susceptibility
S. no Specimen CFW Gram 20 % ZN Culture No. of days
for growth
Organism A Cz Ch Cip Gf Mx Of Va G








3 Vitreous – – – BA 3 M. chelonei S R R S R R R R S
CA
BHI
4 Vitreous – GPB 0–5/OIF AFB—plenty/OIF BA 3 M. manitobensea S S S S S S S S ND
CA
5 IOL+ Vitreous +
AC exudates




ZN Ziehl-Neelsen, GPB gram-positive bacilli, AFB acid fast bacilli, OIF oil immersion field, Neg negative, ND not done, A amikacin, Cz cefazolin, Ch chloramphenicol,
Cip ciprofloxacin, Gf gatifloxacin, G gentamicin, Mx moxifloxacin, Of ofloxacin, Va vancomycin, S sensitive, R resistant, IOL intraocular lens, CFW calcofluor white stain
aThe identification was confirmed by 16S rDNA sequencing and phylogenetic analysis
Fig. 2 Microbiological investigation of non-tuberculous mycobacteria endophthalmitis—patient no. 5. a Growth of tiny, cream, moist bacterial
colonies around intraocular lens plated on blood agar (incubation—37 °C, 3 days). b Direct smear examination of vitreous lavage showing plenty
of polymorphonuclear cells, brown uveal pigments, and pink long, slender, beaded acid fast bacilli (ZN stain, ×1000)
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be almost six times more likely to end up with loss of
vision, in contrast to eyes with a history of a foreign body
[13]. Previous reports also suggest that patients usually
present within days and up to 35 weeks after initial inter-
vention, with an average of 11.5 weeks [13]. Our series of
patients had varied duration of presentation with a mini-
mum of 13 days after vitreo-retinal intervention and
maximum of 300 days after cataract surgery. Since atypical
mycobacteria can be found in tap and distilled water, con-
taminated water is likely to be a source of the infection.
Some mycobacterial species have resistance to commonly
used disinfectants, which makes contamination of certain
surgical instruments more likely [17]. It is possible that
breach in sterility during surgery led to the infection in
the former; however, it is difficult to speculate the mode
of infection in the latter.
The threshold for clinical suspicion is likely to be high
owing to rarity of the condition and may account for
delay in diagnosis. The clinical picture mimics infections
caused by other low virulent micro-organisms. Clinically,
NTM endophthalmitis may mimic Propionibacterium
acnes endophthalmitis due to the common presentation
of exudative membrane between IOL and posterior cap-
sule [18]. In the present study, the patients (#3, #4) who
underwent anterior segment surgeries had intense anter-
ior chamber reaction with fluffy endoexudates suggestive
of fungal endophthalmitis. Therefore, these patients
were empirically given intravitreal antifungal injection
in addition to antibacterial antibiotics.
The vast majority of NTM infections are caused by
the Runyon group IV organisms M. fortuitum and M.
chelonae. Other less common species include Mycobac-
terium sulzi, Mycobacterium flavescens, Mycobacterium
avium-intracellulare, Mycobacterium gordonae, and
Mycobacterium marinum [18–21]. We have earlier re-
ported the presence of partially stained or unstained
gram-positive bacilli in corneal scraping being a clue for
the presence of acid fast organism [22]. A similar clue
was seen in the microscopic examination of the Gram
stain of the vitreous in two of our patients which led to
staining with ZN stain. Mycobacterial infection is gener-
ally not suspected in postoperative endophthalmitis, and
the poorly staining gram-positive bacilli, as in our pa-
tient no. 4, at times could be mistaken as diphtheroids
(Corynebacterium species). Hence, special stains such as
Ziehl-Neelsen stain should be used. However, unlike the
common pathogenic mycobacteria, the M. fortuitum com-
plex group grows well on routine bacteriologic media such
as blood agar and MacConkey agar, as well as on the
Lowenstein Jensen medium at temperatures ranging from
25 to 40 °C, in less than 7 days. They form colonies that are
smooth, rough, or a mixture of both. M. fortuitum complex
consists of two species—M. fortuitum and M. chelonae.
M. chelonae has three subspecies—abscessus, chelonae,
and an un-named species (known as M. chelonae-like
organisms). Mycobacteria in this group grow rapidly,
forming non-pigmented colonies in culture at room
temperature within 3–5 days instead of the 2–3 weeks
required by other mycobacteria [14]. In all the patients
in this series, the organism could be identified with in a
period of 3–4 days and growth was observed on routine
blood agar and chocolate agar media. This indicates
that NTM can grow on conventional media and broth,
and special media are usually not required. Although
the members of Runyon group IV produce positive cultures
within 7 days, the infection caused by slow growers is likely
to be missed on routine microbiology as culture plates are
often discarded after 7 days.
Rapidly growing NTM (RGNTM) endophthalmitis
should be considered in the differential diagnosis of re-
fractory anterior chamber and vitreous inflammation, as
expedient identification and management is necessary to
prevent poor visual outcomes. Standard biochemical
testing can identify the causative organism but is limited
by the inability to distinguish between RGNTM species
reliably, as demonstrated by our recent experience with
the isolate of case no. 4 that was identified by Vitek 2
compact system as Corynebacterium pseudodiphtheriti-
cum. In Ziehl-Neelsen staining using 20 % H2SO4 (done
routinely in our laboratory for all gram-positive bacilli to
rule out Mycobacterium sp.) of the culture smear, 40–
50 % of the cells showed acid fast staining that led us to
subject the isolate at a later stage to 16S rDNA sequen-
cing. The sequence analysis confirmed the isolate to be
M. manitobense, heretofore unreported from vitreous of
patients with endophthalmitis [16]. This experience
revalidates our practice of Ziehl-Neelsen staining of all
culture isolates of gram-positive bacilli. The recent paper
by Shah et al. [15] also used DNA sequencing for the
identification of seven subspecies of M. chelonae/absces-
sus in their series. We thus recommend the use of poly-
merase chain reaction (PCR) in conjunction with 16S
rDNA sequencing for reliable differentiation of RGNTM
ocular infections. However, cultures remain critical to
therapy, as antibiotic susceptibility test results on cultured
strains are the best guide to antibiotic selection, given the
rapidly rising resistance to antimicrobials within RGNTM
strains as evidenced in our study.
A favourable outcome defined as final best-corrected
visual acuity of 20/200 or better was found in only one
patient, which was similar to the study by Shah et al.
[15] wherein the visual outcomes in these patients even
after treatment were generally poor. This could be at-
tributed to multiple factors including high virulence of
the organism and delayed presentation of the patients.
The limitations of the current study include its retro-
spective design, relatively small number of patients, and
use of positive vitreous cultures as the inclusion criteria
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for the study. Despite these limitations, this study pro-
vides important prognostic and antibiotic resistance data
for endophthalmitis caused by non-tubercular mycobac-
teria species.
Conclusions
Based on our study, we may conclude that NTM is an
uncommon condition but should be considered in the
differential diagnosis of delayed-onset, chronic endoph-
thalmitis after ocular surgeries especially with an implant.
Therefore, when rapidly growing mycobacteria are recov-
ered from patients with endophthalmitis, amikacin should
be included in the therapeutic regimen until speciation
and in vitro susceptibility testing suggest equally effica-
cious alternatives. Despite the use of sensitive antibiotics,
several patients of NTM infection do not respond to
medical treatment and require surgical intervention.
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